Skip to main content
. Author manuscript; available in PMC: 2016 Feb 18.
Published in final edited form as: Biomaterials. 2014 Sep 15;35(37):9951–9962. doi: 10.1016/j.biomaterials.2014.08.037

Fig. 4. CeO2 nanoparticle administration attenuates monocrotaline–induced increases in cardiomyocyte cross sectional area and cardiac fibrosis.

Fig. 4

Dystrophin stained right ventricular sections from control (Panel A), MCT only (Panel B), and MCT + CeO2 nanoparticle treatment group (Panel C). Quantification of cardiomyocyte cross sectional area (Panel D). Picrosirius red staining was used to evaluate cardiac fibrosis in the right ventricles of control (Panel E), MCT only (Panel F) and MCT + CeO2 nanoparticle treatment groups (Panel G). Scale bar = 50 μm. Data are mean ± SEM (n = 3 rats/group). * Significantly different from control. † Significantly different from the MCT only group (P < 0.05).